Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 606 results for "amgen rank"

Amgen Inc. Bonds: A Rare Combination Of Low Risk And High Value
Seeking Alpha

Amgen Inc. Bonds: A Rare Combination Of Low Risk And High Value

Summary Amgen default probabilities rank in the best 1% of 445 pharmaceutical and health care firms at all maturities. Amgen bonds also offer a very strong ratio of credit spread to default probabilities at all maturities. Among heavily traded ... Seeking Alpha, 3 weeks ago

2 images for "amgen rank"

Rediff.com, 2 weeks ago
Benzinga.com, 3 months ago

Potential Amgen (AMGN) Trade Targets 4.52% Return

Amgen Inc ( AMGN ) traded between $121.00 and $122.39 before closing at $122.01 Wednesday and presents some attractive trading opportunities today according to MarketIntelligenceCenter.com's patented algorithms. The computer program that picks ...
 TradingCharts.com46 minutes ago Amgen (AMGN) Trading Near $120.66 Resistance Level  Individual.com1 day ago Potential Amgen (AMGN) Trade Has 3.10% Downside Protection  Individual.com6 days ago Amgen (AMGN) Trading Near $120.53 Resistance Level  Individual.com1 week ago
[x]  

The Zacks Analyst Blog Highlights: AbbVie, Shire, Amgen, InterMune and Biogen

/PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog ...
 Town Hall3 hours ago THE ZACKS ANALYST BLOG HIGHLIGHTS : AbbVie, Shire, Amgen, InterMune and Biogen  4 Traders3 hours ago The Zacks Analyst Blog Highlights:Regado Biosciences, Jazz Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi and Amgen  Wall Street Select2 weeks ago Where Are We At With AbbVie's Acquisition Of Shire?  Seeking Alpha1 week ago
[x]  

Amgen's AMG 416 Succeeds in Phase III, Shares Up

Amgen Inc. 's ( AMGN ) shares were up 2.5% following the company's announcement that AMG 416 (formerly known as velcalcetide) has met the primary as well as secondary endpoints in a randomized, double-blind, placebo-controlled 26-week long phase III ...
 Yahoo! Finance3 days ago

Amgen (AMGN) Showing Bullish Technicals With Resistance At $120.00

Amgen Inc (http://www.marketintelligencecenter.com/symbol/AMGN"AMGN) presents a trading opportunity that offers a 7.31% return in just 99 days. A covered call on Amgen at the $125.00 level expiring on Oct. '14 offers an assigned return rate of ...
 Individual.com1 week ago Amgen (AMGN) Showing Support Near $111.22  TradingCharts.com2 months ago

BIND Therapeutics Ends Oncology Deal with Amgen

BIND Therapeutics, Inc. ( BIND ) announced the completion of its one and a half year old agreement with Amgen Inc. ( AMGN ). In Jan 2013, the two companies had entered into a one-year collaboration agreement to optimize a specific therapeutic ...
 Yahoo! Finance2 weeks ago
[x]  
Bangkok Post

Cavendish to lead Omega Pharma at Tour de France

Mark Cavendish of Great Britain riding for the Omega Pharma-Quickstep Cycling Team celebrates during the 2014 Amgen Tour of California on May 18, 2014 in Thousand Oaks Winner of 25 Tour stages, which is third on the all-time list, nine behind ...
 Bangkok Post1 month ago

Amgen (AMGN) Showing Resistance Near $117.15

MarketIntelligenceCenter.com's patented algorithms have selected a trade on Amgen Inc (http://www.marketintelligencecenter.com/symbol/AMGN"AMGN) that returns 40.85% in 127 days for an annualized return rate of 117%. This diagonal spread pairs a ...
 Individual.com1 month ago

Amgen-AstraZeneca Psoriatic Arthritis Drug Shows Improvement

AstraZeneca ( AZN ) and partner Amgen ( AMGN ) announced that data from a phase II study (n = 168) evaluating the use of brodalumab in patients suffering from psoriatic arthritis was published in The New England Journal of Medicine (:NEJM). The data ...
 Yahoo! Finance1 month ago
[x]  

Amgen's Vectibix Label Expanded

Amgen Inc. ( AMGN ) announced a label expansion for its oncology drug Vectibix in the U.S. Vectibix can now be used for the first-line treatment of patients suffering from wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC). The U.S. Food ...
 Yahoo! Finance1 month ago Amgen's Vectibix Label Expanded - Analyst Blog  Benzinga.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less